Cumulative abnormal return

(redirected from Cumulative Abnormal Returns)

Cumulative abnormal return (CAR)

Sum of the differences between the expected return on a stock (systematic risk multiplied by the realized market return) and the actual return often used to evaluate the impact of news on a stock price.
Copyright © 2012, Campbell R. Harvey. All Rights Reserved.

Cumulative Abnormal Return

In stocks, the sum of all the differences between the expected returns and the actual returns up to a given point in time. Since the expected return is computed by an asset pricing model, the cumulative abnormal return may be used to determine how accurate the model is. More often, it is used to investigate the affect extraneous events have on stock prices.
Farlex Financial Dictionary. © 2012 Farlex, Inc. All Rights Reserved
References in periodicals archive ?
To help fill this gap using the CARs measure (cumulative abnormal returns of stock prices), outsourcing announcements were analyzed for a 14-year period ending in 2004 to assess stock price movements vis a vis the announced outsourcing rationale.
We estimate daily abnormal returns (DARs) and cumulative abnormal returns (CARs) for these nine episodes.
Because of the possible information-leakage phenomenon we also use cumulative abnormal returns (CAR) metric to measure abnormal activity over trading intervals constituting days before and after the announcement.
Additionally, since the cumulative abnormal returns are larger in firms with faster growing sales, investors may be telling managers of firms growing quickly that they may be expected to spin-off non-essential activities more so than managers of slow growth organizations.
For our analysis, we use both portfolio and individual cumulative abnormal returns for three days after the terrorist attacks.
The cumulative abnormal returns come down to zero after the 30th month of the splits.
The second and third column show the Cumulative Abnormal returns (CAR) and Cumulative Average Abnormal returns (CAAR) respectively.
Table 2 reports the correlation between the weighted average cumulative abnormal returns of business group affiliated firms (WCAR) with their corresponding focal firm's cumulative abnormal return (FCAR).
According to previous researchers suggest that that abnormal performance measures such as standardized cumulative abnormal returns (SCARs) are less likely to generate false rejections of market efficiency.